AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive disorder (MDD), for up to $1.

President Donald Trump has signed the HALT Fentanyl Act into law which gives law enforcement more power in the fight against ...

Governor Mike DeWine has called on the Ohio Board of Pharmacy to immediately classify all natural and synthetic kratom ...

Sudden death of 17-year-old girl and hospitalisations sparks fears of high-strength ecstasy as Electric Picnic approaches ...

AbbVie agreed to pay up to $1.2 billion to buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major ...

The interview unveils how this internationally recognized researcher, whose work has been continuously funded by the National Institutes of Health for an unprecedented 42 years, developed innovative ...

In addition, Okolo, 38, and Chukwuka, 31, were accused of managing the transportation and delivery of 128 kilogrammes of ...

The asset deal thrusts AbbVie to the forefront of the psychedelic field, handing it a therapy that recently scored positive ...

AbbVie will buy an experimental depression drug from partner Gilgamesh Pharmaceuticals for up to $1.2 billion, the companies said on Monday, seeking to access a fast-growing market for ...

A 48-year-old man was caught Thursday with large quantities of crack cocaine, methamphetamine, ecstasy, mushrooms, LSD, ...

Madhavaram police arrest five men for drug peddling, seize LSD stamps and MDMA tablets; suspects identified and belongings confiscated.

Acting on a tip-off, police caught Anas Abdul (22) from TT Nagar with 150 Nitravet-10 tablets. His links led to the arrest of ...